EsCApetHEmAtRiCS

INJ/USDT RELOADED CHART

Long
EsCApetHEmAtRiCS Mis à jour   
BINANCE:INJUSDT   INJ / TetherUS

Note - I'M publishing this chart again coz previous published chart of the same idea was hidden by moderators coz of house rule violation.

SPOT BUY CALL (BUY & HODL) buy INJECTIVE protocol (inj) in 3 parts : 1st buy - @ 2.75 , 2nd buy 20% below the first buying price ,
3rd buy 20% below from 2nd buy price
stop-loss should be placed below ma 200 which is @ $1.692. take profit zone 1ST- $3.8 -$4 take profit 2nd zone - $4 - $6.


always DO YOUR OWN RESEARCH before taking any trade or before investing your hard earned money.

Suggestion/Tip – It is always better to take profit, whether all the zones are bought or not.

Suggestion/Tip 2 - When price is moving on right way
"it is always recommended to move stop-loss to profit side".

If you like the idea and benefited from it please like , share & comment to keep us motivated.
Transaction en cours:
#INJ first target zone hit 🎯
We are in 47% profit from our first entry.
Commentaire:
#INJ went up-to $4.37 , so technically it entered our tp 2 zone also. It went 59% up from our first entry. If you guys booked the profit den perfect but if not , in that case i hope you have trailed your stop-loss to the profit zone at-least.

always DO YOUR OWN RESEARCH before taking any trade or before investing your hard earned money.

Suggestion/Tip – It is always better to take profit, whether all the zones are bought or not.

Suggestion/Tip 2 - When price is moving on right way
"it is always recommended to move stop-loss to profit side".

If you like the idea and benefited from it please like , share & comment to keep us motivated.
Trade fermée: cible de profit atteinte:
Target reached fully.

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.